ESC 365 - Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: the RELAX-AHF-ASIA trial

HFA Premium Access

Evaluating the efficacy, safety and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: the RELAX-AHF-ASIA trial

Session: Clinical Forum - Sat.26 May 08:30 - Tues. 29 May at 12:30

Topic: Pharmacotherapy

Speaker: Professor N. Sato (Kawaguchi, JP)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Naoki Sato

Kawaguchi Cardiovascular and Respiratory Hospital, Kawaguchi (Japan)

6 presentations

0 follower

12 more presentations in this session

The influence of heart transplant on sexual activity

Speaker: Mr G. Vasoncelos (Fortaleza, BR)

Home-based rehabilitation for heart failure with reduced ejection fraction: randomised controlled trial

Speaker: Professor R. Taylor (Glasgow, GB)

Snapshot evaluation of acute and chronic heart failure in real life in Turkey: complete adherence to guideline directed medications shrinks excess mortality

Speaker: Professor M. Yilmaz (Izmir, TR)

Development of an aging female rat model of HFpEF and evaluation of the antifibrotic potential of (-)-epicatechin

Speaker: Doctor F. Villarreal (La Jolla, US)

Incidence of associations with and prognostic impact of worsening renal function in heart failure with different ejection fraction categories

Speaker: Doctor I. Lofman (Stockholm, SE)

Access the full session

Clinical Forum - Sat.26 May 08:30 - Tues. 29 May at 12:30

Speakers: Professor N. Sato, Mr G. Vasoncelos, Professor R. Taylor, Professor M. Yilmaz, Doctor F. Villarreal...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources